- Home
- INBK vs LXRX Comparison
INBK vs LXRX Comparison
Compare INBK & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBK
- LXRX
- Stock Information
- Founded
- INBK 1999
- LXRX 1995
- Country
- INBK United States
- LXRX United States
- Employees
- INBK N/A
- LXRX N/A
- Industry
- INBK Major Banks
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- INBK Finance
- LXRX Health Care
- Exchange
- INBK Nasdaq
- LXRX Nasdaq
- Market Cap
- INBK 196.2M
- LXRX 228.8M
- IPO Year
- INBK N/A
- LXRX 2000
- Fundamental
- Price
- INBK $27.81
- LXRX $0.92
- Analyst Decision
- INBK Buy
- LXRX Buy
- Analyst Count
- INBK 4
- LXRX 4
- Target Price
- INBK $34.50
- LXRX $3.67
- AVG Volume (30 Days)
- INBK 41.3K
- LXRX 5.3M
- Earning Date
- INBK 07-23-2025
- LXRX 07-31-2025
- Dividend Yield
- INBK 0.87%
- LXRX N/A
- EPS Growth
- INBK 27.37
- LXRX N/A
- EPS
- INBK 2.40
- LXRX N/A
- Revenue
- INBK $114,609,000.00
- LXRX $31,213,000.00
- Revenue This Year
- INBK $5.36
- LXRX N/A
- Revenue Next Year
- INBK $17.09
- LXRX N/A
- P/E Ratio
- INBK $11.55
- LXRX N/A
- Revenue Growth
- INBK 20.13
- LXRX 1251.21
- 52 Week Low
- INBK $19.54
- LXRX $0.28
- 52 Week High
- INBK $43.27
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- INBK 68.55
- LXRX 62.67
- Support Level
- INBK $26.63
- LXRX $0.80
- Resistance Level
- INBK $28.12
- LXRX $0.96
- Average True Range (ATR)
- INBK 0.91
- LXRX 0.08
- MACD
- INBK 0.40
- LXRX 0.02
- Stochastic Oscillator
- INBK 93.99
- LXRX 83.61
About INBK First Internet Bancorp
First Internet Bancorp is a bank holding company. Through its subsidiaries, it provides commercial real estate (CRE) lending, including nationwide single tenant lease financing and commercial and industrial (C&I) lending, including business banking or treasury management services. The company offers its products and services through the internet and does not have any branches. With operations organized into a single segment called the Commercial Banking segment, it also provides retail banking services.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.